- Home
- MBAI vs MDAI Comparison
MBAI vs MDAI Comparison
Compare MBAI & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MBAI | MDAI |
|---|---|---|
| Founded | 2004 | 2013 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.1M | 48.0M |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MBAI | MDAI |
|---|---|---|
| Price | $2.29 | $1.52 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | ★ $5.11 |
| AVG Volume (30 Days) | 24.4K | ★ 128.9K |
| Earning Date | 11-20-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 65.88 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $19,650,000.00 |
| Revenue This Year | $103.86 | N/A |
| Revenue Next Year | $231.30 | $74.98 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.95 | $1.18 |
| 52 Week High | $10.21 | $2.97 |
Technical Indicators
Market Signals| Indicator | MBAI | MDAI |
|---|---|---|
| Relative Strength Index (RSI) | 40.92 | 48.32 |
| Support Level | $1.33 | $1.46 |
| Resistance Level | $2.64 | $1.67 |
| Average True Range (ATR) | 0.25 | 0.08 |
| MACD | 0.14 | 0.00 |
| Stochastic Oscillator | 65.55 | 58.00 |
Price Performance
Historical ComparisonAbout MBAI Check-Cap Ltd. Ordinary Share
MBody AI Ltd develops enterprise software to deploy and manage autonomous robot workforces for hospitality and gaming operators. The Company's proprietary MBody AI Orchestrator is a hardware-agnostic software platform that manages diverse robot fleets from multiple vendors across sites and use cases under long-term agreements. MBody AI serves Fortune 500 operators as customers.
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.